NFIB is a potential target for estrogen receptor-negative breast cancers

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance

(2010) Y. Mitani et al.   CLINICAL CANCER RESEARCH

Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer

(2010) Musaffe Tuna et al.   PLoS One

Up-regulation of RhoGDI2 in Human Breast Cancer and Its Prognostic Implications

(2010) Hyeong-Gon Moon et al.   Cancer Research and Treatment

miR-21as a key regulator of oncogenic processes

(2009) S. Duygu Selcuklu et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

HMGA2–NFIB fusion in a pediatric intramuscular lipoma: a novel case of NFIB alteration in a large deep-seated adipocytic tumor

(2009) Anne Pierron et al.   CANCER GENETICS AND CYTOGENETICS

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

(2009) M. Persson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s

(2008) Henrike E. Karim-Kos et al.   EUROPEAN JOURNAL OF CANCER

NFIBrearrangement in superficial, retroperitoneal, and colonic lipomas with aberrations involving chromosome band 9p22

(2008) Antoine Italiano et al.   GENES CHROMOSOMES & CANCER

DNA copy number alterations and expression of relevant genes in triple-negative breast cancer

(2008) Wonshik Han et al.   GENES CHROMOSOMES & CANCER

miR-21 Gene Expression Triggered by AP-1 Is Sustained through a Double-Negative Feedback Mechanism

(2008) Shuji Fujita et al.   JOURNAL OF MOLECULAR BIOLOGY